Many patients wonder whether taking their weekly injection on an empty stomach improves effectiveness, but the science suggests food timing matters less than consistency
On just the Hims & Hers platform alone, nearly 80,000 individuals have shared they cannot access branded GLP-1 medications
That's a 5-minute check that turns a $294 commitment into a genuinely risk-free trial
By using lower doses than the standard escalation protocol, patients can stretch their medication supply and reduce monthly expenditure
By mapping this elasticity, we can project exactly how the market will fracture into three tiers post-2026: Tier 1: The Premium Niche (Current State) Reach: 20 - 30 Million people
Patients enrolled in clinical trials should discuss any new or worsening symptoms with their trial team before self-managing with additional medications, to ensure there are no interactions or contraindications relevant to their specific trial protocol